Checkpoint therapeutics, inc. (CKPT)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Dec'15
ASSETS
Current Assets:
Cash and cash equivalents

21,481

26,077

13,060

13,205

14,147

21,995

29,600

28,304

34,863

19,225

23,418

27,225

32,298

35,086

39,354

50,418

Prepaid expenses and other assets

753

863

740

967

1,064

1,372

1,196

528

1,222

1,857

1,892

874

218

71

24

171

Other receivables - related party

-

-

-

-

-

-

-

-

-

-

350

843

693

-

-

-

Other receivables - related party

972

26

280

1,051

77

1,532

5

127

344

331

-

-

-

821

574

65

Total current assets

23,206

26,966

14,080

15,223

15,288

24,899

30,801

28,959

36,429

21,413

25,660

28,942

33,209

35,978

39,952

50,654

Total Assets

23,206

26,966

14,080

15,223

15,288

24,899

30,801

28,959

36,429

21,413

25,660

28,942

33,209

35,978

39,952

50,654

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable and accrued expenses

5,839

7,257

6,907

7,093

7,407

12,317

8,118

5,988

7,000

5,762

5,347

3,815

3,952

3,355

4,166

1,288

Accounts payable and accrued expenses - related party

1,149

862

904

921

803

776

664

667

530

610

496

292

356

318

293

502

Total current liabilities

6,988

8,119

7,811

8,014

8,210

13,093

8,782

6,655

7,530

6,372

5,843

4,107

4,308

3,673

4,459

1,790

Note payable, long-term (net of debt discount of $0 and $324 at December 31, 2016 and December 31, 2015, respectively)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,468

Total Liabilities

6,988

8,119

7,811

8,014

8,210

13,093

8,782

6,655

7,530

6,372

5,843

4,107

4,308

3,673

4,459

4,258

Commitments and Contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

Stockholders' Equity
Common Stock Value

5

5

3

3

3

3

3

3

3

2

2

2

2

2

2

1

Common stock issuable, 1,459,305 shares as of March 31, 2020 and December 31, 2019

2,510

2,510

0

0

0

1,748

0

0

0

2,296

0

0

0

3,919

0

3,024

Additional paid-in capital

137,094

136,442

117,550

113,284

108,361

105,451

105,793

96,734

96,690

71,772

72,926

72,016

69,634

64,736

63,520

57,262

Accumulated deficit

-123,400

-120,111

-111,285

-106,079

-101,287

-95,397

-83,778

-74,434

-67,795

-59,030

-53,112

-47,184

-40,736

-36,353

-28,030

-13,892

Total Stockholders' Equity

16,218

18,847

6,269

7,209

7,078

11,806

22,019

22,304

28,899

15,041

19,817

24,835

28,901

32,305

35,493

46,396

Total Liabilities and Stockholders' Equity

23,206

26,966

14,080

15,223

15,288

24,899

30,801

28,959

36,429

21,413

25,660

28,942

33,209

35,978

39,952

50,654

Class A Common Shares [Member]
Common Stock Value

1

1

1

1

1

1

-

-

-

1

-

-

-

-

-

-

Total Stockholders' Equity

1

1

1

1

1

1

-

-

-

1

-

-

-

-

-

-